M1 Macrophage-Derived Extracellular Particles Induce Cell Death in MDA-MB-231 Cells

Parth Desai1, Anjali Kumari2, Saqer Al Abdullah2

  • 1Department of Nanoscience, Joint School of Nanoscience and Nanoengineering, University of North Carolina at Greensboro, Greensboro, North Carolina, USA.

PubMed
Abstract

Insights

Extracellular particles (EPs) from M1 macrophages induce cell death in triple-negative breast cancer (TNBC) cells. This finding suggests macrophage-derived EPs could offer novel therapeutic strategies for TNBC treatment.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Triple-negative breast cancer (TNBC) is a deadly disease with limited treatment options.
  • Macrophages play a key role in immune responses and can secrete extracellular particles (EPs).
  • EPs are involved in intercellular communication and immune modulation, suggesting potential therapeutic roles.

Purpose of the Study:

  • To investigate the therapeutic potential of M1 macrophage-secreted EPs against TNBC.
  • To examine the effects of M1 EPs on TNBC cell viability and death.

Main Methods:

  • RAW 264.7 macrophages were polarized to M1 phenotype.
  • Macrophage-derived EPs were isolated and characterized using nanoparticle tracking analysis, electron microscopy, and western blotting.
  • The impact of M1 EPs on MDA-MB-231 (TNBC) cells was assessed via confocal microscopy, observing caspase 3/7 expression and cell death.

Main Results:

  • M1 macrophage-derived EPs were successfully isolated and characterized.
  • Exposure to M1 EPs led to a time-dependent increase in caspase 3/7 expression in TNBC cells.
  • M1 EPs induced cell death in TNBC cells, whereas M2 EPs promoted proliferation.

Conclusions:

  • EPs derived from M1 macrophages demonstrate a capacity to induce cell death in TNBC cells.
  • These findings highlight the potential of M1 macrophage-derived EPs as a novel therapeutic approach for TNBC.